Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander D Miras

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|October 4, 2021
Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysisPetr Borodavkin, William Sheridan, Claudia Coelho, et al.
European Journal of Endocrinology|September 1, 2017
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypassGeorge Tharakan, Preeshila Behary, Nicolai J Wewer Albrechtsen, et al.
Lancet (London, England)|February 24, 2015
Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormoneAlexander D Miras, Julianne T Mogford, John Wright, et al.
Diabetologia|April 21, 2015
Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control studyAlexander D Miras, Ling Ling Chuah, Nofal Khalil, et al.
Diabetes, Obesity & Metabolism|September 29, 2020
Imperial Satiety Protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesitySaira Hameed, Victoria Salem, Haya Alessimii, et al.
Diabetes, Obesity & Metabolism|February 22, 2023
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled studyPreeshila Behary, Haya Alessimii, Alexander D Miras, et al.
Trials|February 16, 2024
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)Ebaa Al-Ozairi, Kavita Narula, Alexander D Miras, et al.
Journal of Proteome Research|January 23, 2013
Urinary phenotyping indicates weight loss-independent metabolic effects of Roux-en-Y gastric bypass in miceFlorian Seyfried, Jia V Li, Alexander D Miras, et al.
Obesity Surgery|August 3, 2019
Metabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity SurgeryAlexander D Miras, Saranya Ravindra, Anna Humphreys, et al.
Endocrine Reviews|August 10, 2023
Obesity-Related Hypogonadism in WomenPei Chia Eng, Maria Phylactou, Ambreen Qayum, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|October 4, 2021
Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysisPetr Borodavkin, William Sheridan, Claudia Coelho, et al.
European Journal of Endocrinology|September 1, 2017
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypassGeorge Tharakan, Preeshila Behary, Nicolai J Wewer Albrechtsen, et al.
Lancet (London, England)|February 24, 2015
Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormoneAlexander D Miras, Julianne T Mogford, John Wright, et al.
Diabetologia|April 21, 2015
Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control studyAlexander D Miras, Ling Ling Chuah, Nofal Khalil, et al.
Diabetes, Obesity & Metabolism|September 29, 2020
Imperial Satiety Protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesitySaira Hameed, Victoria Salem, Haya Alessimii, et al.
Diabetes, Obesity & Metabolism|February 22, 2023
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled studyPreeshila Behary, Haya Alessimii, Alexander D Miras, et al.
Trials|February 16, 2024
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)Ebaa Al-Ozairi, Kavita Narula, Alexander D Miras, et al.
Journal of Proteome Research|January 23, 2013
Urinary phenotyping indicates weight loss-independent metabolic effects of Roux-en-Y gastric bypass in miceFlorian Seyfried, Jia V Li, Alexander D Miras, et al.
Obesity Surgery|August 3, 2019
Metabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity SurgeryAlexander D Miras, Saranya Ravindra, Anna Humphreys, et al.
Endocrine Reviews|August 10, 2023
Obesity-Related Hypogonadism in WomenPei Chia Eng, Maria Phylactou, Ambreen Qayum, et al.
Pageof 8